GlassScriptPhysician profile
Paul M Krautter
NPI 1386608453
$7,048.47
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $1,123 · 2021: $1,546 · 2022: $1,267 · 2023: $1,143 · 2024: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $876.75 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $818.81 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $697.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $472.82 | 2019-2024 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $469.49 | 2019-2024 | Ofev, Jardiance |
| Mylan Specialty L.P. | $431.33 | 2019-2024 | Yupelri |
| Daiichi Sankyo INC. | $428.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $372.26 | 2019-2023 | Trelegy Ellipta |
| Pfizer INC. | $362.77 | 2019-2024 | |
| Amarin Pharma, INC. | $308.71 | 2019-2021 | |
| Amgen INC. | $284.86 | 2019-2024 | Repatha, Otezla, Prolia |
| Biohaven Pharmaceuticals, INC. | $206.26 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $187.55 | 2019-2024 | |
| Horizon Therapeutics Plc | $148.70 | 2021-2022 | |
| Lilly USA, LLC | $112.57 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $110.70 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $95.47 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Abbott Laboratories | $85.34 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.19 | 2022 | |
| Biogen, INC. | $56.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $55.36 | 2019-2022 | |
| Allergan, INC. | $48.67 | 2019-2020 | |
| Astellas Pharma US INC | $41.39 | 2019 | |
| Jazz Pharmaceuticals INC. | $39.71 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.73 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.18 | 2021 | |
| Medtronic, INC. | $28.45 | 2022-2024 | Intellis Adaptivestim |
| Eisai INC. | $26.83 | 2020-2021 | |
| Inari Medical, INC. | $26.10 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $23.71 | 2021 | |
| Fisher & Paykel Healthcare INC | $20.12 | 2021 | |
| Axsome Therapeutics, INC. | $19.54 | 2024 | Auvelity |
| Exact Sciences Corporation | $17.07 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $14.50 | 2024 | Dexcom G6 Transmitter |
| Medtronic USA, INC. | $12.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Krautter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.